Blood Collection of Patient Presenting in the ED and Prescribed a BNP
Overview
Plasma specimen collected from patients presenting in the Emergency Department (ED) with or without Heart Failure (HF) and prescribed a BNP.
Full Title of Study: “A Blood Collection From Patients Presenting in the Emergency Department and Prescribed a Brain Natriuretic Peptide (BNP) Laboratory Test”
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Prospective
- Study Primary Completion Date: August 2016
Detailed Description
Plasma samples are collected from a minimum of 400 subjects. Specimens are used to confirm the currently accepted BNP cut off as and aid in the diagnosis and assessment of HF. Stored specimens for future use in BNP assay development.
Interventions
- Device: In Vitro diagnostic tests
- Prospective blood collection
Clinical Trial Outcome Measures
Primary Measures
- Measure BNP
- Time Frame: 6 months
- 400 subjects
Participating in This Clinical Trial
Inclusion Criteria
- Males and females >21 years of age – Able to understand and willing to provide informed consent – Present in to ED – BNP test requested Exclusion Criteria:
- Males and females< 21 years – Unable to provide informed consent – Not presenting to ED – hemolyzed sample
Gender Eligibility: All
Minimum Age: 21 Years
Maximum Age: N/A
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Fujirebio Diagnostics, Inc.
- Provider of Information About this Clinical Study
- Sponsor
- Overall Official(s)
- Diana Dickson, RAC, Study Director, Fujirebio Diagnostics, Inc.
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.